led by passionate experts

Pharma GenLab 81418
Z - Code Consulting Services

Applying for Z – Code 81418 Certification from Palmetto GBA, the MoIDx program can indeed be a complex process. Requiring careful attention to detail and adherence to specific guidelines. 

Palmetto MoIDx Certified

We have been through the certification process, and we are here to guide you through yours.

81418 Z - Code

Multiple gene analysis for drug metabolism. Helping doctors personalize medication dosage and treatment.

0

Years Of Research Experience

Accurate Testing By Expert Scientists

Get results swiftly, with real accuracy. Serving multiple markets as a premier laboratory service throughout Ohio, Pennsylvania, and the Central US. 

about Pharma GenLABS

We Are A Modern Research Expert Company

PharmaGen Labs’ Z-Code Consulting 81418 service empowers your modern research laboratory with industry-leading molecular diagnostics expertise. Our team guides you seamlessly through the DEX™ Diagnostic Exchange registration process, ensuring your laboratory-developed tests (LDTs) and expanded panels receive the precise Z-Code identifier needed for optimal reimbursement. By leveraging cutting-edge analytics and an in-depth understanding of MoIDX Palmetto GBA requirements, we help your lab stay compliant, reduce administrative burden, and focus on scientific innovation.

Lab Specialists

Our specialists handle every step of your Z-Code 81418 submission, minimizing errors and accelerating approval so you can devote more time to research.

Compliance Assurance

With real-time updates on regulatory changes and direct liaison with Palmetto GBA, we keep your lab fully compliant and audit-ready.

Contact Us For Excellent Service

Don’t navigate the process alone. We are here to guide and develop your process into certification. Contact us today.

Breakthrough PGx Legislation

Bipartisan effort to advance pharmacogenomic testing reaches the House floor

Crenshaw and Swalwell Introduce Legislation to Advance Personalized Medicine

Representatives Dan Crenshaw and Eric Swalwell have introduced bipartisan legislation aimed at advancing ...

Reps. Swalwell, Crenshaw Present Bill to Address Adverse Drug Events

The bipartisan legislation aims to reduce adverse drug events through expanded access to pharmacogenomic testing, potentially saving lives ...

Representatives Swalwell and Crenshaw Introduce Bipartisan Legislation

The official announcement details how this legislation will help prevent adverse drug events, improve patient care, and pave the way for more personalized medicine approaches ...